Huntsman Carole (CIK 2001571) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-06). Recent activity: Buy MDGL (3,989 shares), Sell MDGL (419 shares), Sell MDGL (340 shares), Sell MDGL (570 shares), Sell MDGL (894 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Buy | 3,989 | $0 |
| 2026-03-06 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 419 | $180,983 |
| 2026-01-26 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 340 | $167,423 |
| 2026-01-26 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 570 | $281,916 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 894 | $492,567 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 144 | $78,807 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 120 | $65,845 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 40 | $21,974 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 200 | $110,476 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 40 | $22,129 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 120 | $66,725 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 200 | $111,920 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 80 | $44,850 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 40 | $22,528 |
| 2025-11-21 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | Sell | 80 | $45,166 |
Source: SEC Form 4 filings · as of 2026-03-06